SCHEMBL6199397

SCHEMBL6199397

Cn1ncc(Br)c1-c1cccc(NC(=O)Nc2ccc(F)c(C(F)(F)F)c2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 15/20 0.71
HTR2C P28335 13/20 0.56
BRAF P15056 1/20 0.51
KDR P35968 3/20 0.49
CSF1R P07333 2/20 0.49
FLT1 P17948 2/20 0.49
FLT4 P35916 2/20 0.49
FLT3 P36888 2/20 0.49
ABL1 P00519 1/20 0.49
LCK P06239 1/20 0.49
LYN P07948 1/20 0.49
KIT P10721 1/20 0.49
SRC P12931 1/20 0.49
BLK P51451 1/20 0.49
RET P07949 1/20 0.48
FGFR1 P11362 1/20 0.48
FRK P42685 1/20 0.48
CAMK2B Q13554 1/20 0.48
CAMK2D Q13557 1/20 0.48
NTRK3 Q16288 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6200025 0.92 HTR2A (0.69) HTR2AHTR2C
SCHEMBL6201549 0.92 HTR2A (0.72) HTR2AHTR2C
SCHEMBL6198546 0.89 HTR2A (0.73) HTR2AHTR2CBRAFKDR
SCHEMBL6196617 0.89 HTR2A (0.60) HTR2AHTR2CBRAFKDRCSF1R
SCHEMBL6199703 0.89 HTR2A (0.78) HTR2AHTR2C
SCHEMBL6198081 0.86 HTR2A (0.80) HTR2AHTR2C
SCHEMBL6196811 0.85 HTR2A (0.64) HTR2AHTR2C
SCHEMBL6201624 0.83 HTR2A (1.00) HTR2AHTR2C
SCHEMBL6200743 0.83 HTR2A (0.72) HTR2AHTR2C
SCHEMBL6197718 0.83 HTR2A (0.69) HTR2AHTR2CKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1509505-A2 SMALL MOLECULE MODULATORS OF THE 5−HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2005-03-02 EP claimed
WO-2003062206-A2 SMALL MOLECULE MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2003-07-31 WO claimed